KR100740416B1 - Process of manufacturing of olive leaf extract with physiological activities - Google Patents
Process of manufacturing of olive leaf extract with physiological activities Download PDFInfo
- Publication number
- KR100740416B1 KR100740416B1 KR1020050078206A KR20050078206A KR100740416B1 KR 100740416 B1 KR100740416 B1 KR 100740416B1 KR 1020050078206 A KR1020050078206 A KR 1020050078206A KR 20050078206 A KR20050078206 A KR 20050078206A KR 100740416 B1 KR100740416 B1 KR 100740416B1
- Authority
- KR
- South Korea
- Prior art keywords
- olive leaf
- extract
- olive
- ethanol
- activity
- Prior art date
Links
- 229940114496 olive leaf extract Drugs 0.000 title claims abstract description 26
- 230000001766 physiological effect Effects 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title abstract description 25
- 230000008569 process Effects 0.000 title description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 89
- 240000007817 Olea europaea Species 0.000 claims abstract description 59
- 239000000284 extract Substances 0.000 claims abstract description 51
- 235000002725 Olea europaea Nutrition 0.000 claims abstract description 33
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 238000010992 reflux Methods 0.000 claims description 8
- 230000004071 biological effect Effects 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 4
- 239000000843 powder Substances 0.000 abstract description 11
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 description 22
- 230000003078 antioxidant effect Effects 0.000 description 20
- 239000002253 acid Substances 0.000 description 18
- 150000002978 peroxides Chemical class 0.000 description 18
- 235000013824 polyphenols Nutrition 0.000 description 17
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 13
- 235000020778 linoleic acid Nutrition 0.000 description 13
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 12
- 239000002034 butanolic fraction Substances 0.000 description 12
- 239000002038 ethyl acetate fraction Substances 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- 230000002000 scavenging effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 229940087168 alpha tocopherol Drugs 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 229960000984 tocofersolan Drugs 0.000 description 6
- 239000002076 α-tocopherol Substances 0.000 description 6
- 235000004835 α-tocopherol Nutrition 0.000 description 6
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 5
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 5
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 5
- 239000012223 aqueous fraction Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000011576 oleuropein Nutrition 0.000 description 5
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 229940093499 ethyl acetate Drugs 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000002036 chloroform fraction Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000002044 hexane fraction Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- QYTOONVFPBUIJG-UHFFFAOYSA-N azane;cyanic acid Chemical compound [NH4+].[O-]C#N QYTOONVFPBUIJG-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000000398 extracts by solvent Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000002030 fractions by solvent Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- -1 linoleic acid peroxide Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 생리활성을 갖는 올리브 잎의 추출물을 제조하는 방법에 관한 것으로서, 유기용매를 사용하지 않고 올리브 잎을 20 내지 30 메쉬로 분쇄한 후, 80%에탄올을 첨가하여 85℃에서 5시간 동안 환류 및 여과하는 단계를 거친 후 40℃에서 진공 농축하여 올리브 잎의 추출물을 제조한다. 또한 위와 같은 단계를 거친 후 올리브 잎 추출물을 동결건조하여 분말의 추출물을 제조하는 방법을 제공한다. The present invention relates to a method for producing an extract of the olive leaf having a physiological activity, after pulverizing the olive leaf 20 to 30 mesh without using an organic solvent, refluxed for 5 hours at 85 ℃ by adding 80% ethanol And after the step of filtration and concentrated in vacuo at 40 ℃ to prepare an extract of the olive leaf. In addition, there is provided a method of preparing an extract of the powder by lyophilizing the olive leaf extract after the above steps.
올리브 잎 Olive leaves
Description
도1은 실시예1에 따른 올리브 잎 추출물 및 분획물들의 아질산염 소거능에 대한 그래프이다.1 is a graph of the nitrite scavenging ability of the olive leaf extract and fractions according to Example 1.
도2는 실시예1에 따른 올리브 잎 추출물 및 분획물들의 SOD유사활성에 관한 그래프이다.Figure 2 is a graph of the SOD-like activity of the olive leaf extract and fractions according to Example 1.
도3은 실시예 1에 따른 올리브 잎 추출물, BHT, 및 a-토코페롤의 리놀레인산 기질의 과산화물가를 측정한 그래프이다.Figure 3 is a graph measuring the peroxide value of the linoleic acid substrate of olive leaf extract, BHT, and a-tocopherol according to Example 1.
도4는 올리브 잎 분획물들의 첨가에 따른 리놀레인산 과산화물가 변화를 측정한 그래프이다.Figure 4 is a graph measuring the change of linoleic acid peroxide with the addition of olive leaf fractions.
도5는 실시예1에 따른 올리브 잎 추출물, BHT, 및 a-토코페롤의 리놀레인산 에멀전 기질의 과산화물 변화를 측정한 그래프이다.Figure 5 is a graph measuring the peroxide change of the linoleic acid emulsion substrate of olive leaf extract, BHT, and a-tocopherol according to Example 1.
도6은 올리브 잎 분획물들의 첨가에 따른 리놀레인산 에멀전 기질의 과산화물 변화를 측정한 그래프이다.Figure 6 is a graph measuring the peroxide change of the linoleic acid emulsion substrate with the addition of olive leaf fractions.
도7은 가열산화시 실시예1에 따른 추출물 및 BHT, a-토코페롤의 공액이중산가의 변화를 측정한 그래프이다.Figure 7 is a graph measuring the change in the conjugated double acid value of the extract and BHT, a-tocopherol according to Example 1 during the heat oxidation.
도8은 가열산화시 올리브 잎 분획물의 공액이중산가의 변화를 측정한 그래프 이다.Figure 8 is a graph measuring the change in the conjugated double acid value of the olive leaf fraction during heating oxidation.
도9는 가열산화시 실시예1에 다른 추출물 및 BHT, a-토코페롤의 산가 변화를 측정한 그래프이다.Figure 9 is a graph measuring the acid value change of BHT, a-tocopherol and other extracts in Example 1 during heating oxidation.
도10은 가열산화시 올리브 잎 분획물의 산가 변화를 측정한 그래프이다.10 is a graph measuring the acid value change of the olive leaf fraction during the heat oxidation.
도11은 OLB5-1 및 oleuropein의 UV스펙트럼을 조사한 결과이다.11 shows the results of UV spectra of OLB5-1 and oleuropein.
도12는 올리브잎 부탄올 추출물로부터 분리된 OLB5-1의 HPLC 크로마토그램이다.12 is an HPLC chromatogram of OLB5-1 isolated from olive leaf butanol extract.
본 발명은 생리활성을 갖는 올리브 잎 추출물의 제조방법에 관한 것이다.The present invention relates to a method for producing olive leaf extract having physiological activity.
예로부터 올리브 잎은 말라리아나 고열 등을 치료하는 목적으로 민간 의약품으로 사용되었고 그 밖에도 고혈압, 아테롬성 동맥경화증, 결장암, 염증, 식중독 등의 증상에 효능이 있으며, 올리브 잎 추출물은 혈압을 낮추거나 관상동맥의 혈류 속도를 증가, 부정맥을 완화, 소장 근육의 경련을 예방하는 등의 효과가 있는 것으로 알려져 왔다. Olive leaf has been used as a folk medicine for the purpose of treating malaria and high fever.In addition, it is effective for hypertension, atherosclerosis, colon cancer, inflammation, and food poisoning. Olive leaf extract lowers blood pressure or coronary artery. It has been known to increase the rate of blood flow, relieve arrhythmia, and prevent spasm of the small intestine muscles.
올리브, 포도 등 지중해성 식물에는 고혈압, 동맥경화 및 심장병과 같은 심혈관계 질환이나 유방암과 결장암 등의 발생율을 낮추는 비타민류, 플라보노이드 및 폴리페놀과 같은 생리활성 화합물등의 함량이 다른 식물류에 비해 높다고 한다. 최근 천연항산화제와 같은 식품의 생리활성 물질들에 대한 관심이 점차 증가하고 있는 것은 지중해성 식물에 함유된 산화방지 효과조서 일부 페놀성 물질들 때문인 것으로 알려졌다.Mediterranean plants such as olive and grapes have higher levels of cardiovascular diseases such as hypertension, arteriosclerosis and heart disease, and bioactive compounds such as vitamins, flavonoids and polyphenols that lower the incidence of breast and colon cancer. . Recently, the increasing interest in bioactive substances in foods such as natural antioxidants is known to be due to some phenolic substances in the antioxidant effect of Mediterranean plants.
따라서, 최근에는 올리브 잎에 존재하는 폴리페놀 중 hydroxytyrosol 과 oleuropein에 대한 연구가 활발하게 이루어지고 있으며, 그 밖에도 rutin, luteolin, catechin 등과 같은 flavonoid류와 caffeic acid, p-coumaric acid와 같은 페놀산들은 비록 올리브 잎에 소량 존재하는 폴리페놀 물질이지만, 최근 주목받고 있는 생리활성 물질군의 하나로서 항산화 작용을 비롯하여, 항암, 항혈전, 항염증, 항알러지 및 항균작용 등 다양한 생리활성들이 보고 되고 있다.
지금까지 알려진 올리브 추출물에 관한 제조방법으로는, 대한민국 특허 공보 10-0449670(발명의 명칭 : 올리브 분말의 제조방법 및 올리브 분말용 조성물)에 따르면 건강 식품용으로 복용하기 위한 올리브 분말의 제조방법 및 올리브 분말용 조성물에 대해 기술하고 있다. 이 발명은 올리브를 파쇄하여 여기에 옥수수 가루, 찰옥수수 알파 전분을 교반기에 넣고 혼합하여 올리브 분말용 조성물을 만드는 교반 혼합 단계, 동결단계, 건조단계, 분쇄단계를 거쳐 개별로 포장하는 올리브 분말을 제조하는 방법에 관한 것으로서, 본원발명의 생체활성을 갖는 올리브 잎 추출물 제조방법과는 현저히 다른 발명이다.Therefore, in recent years, research on hydroxytyrosol and oleuropein among the polyphenols present in olive leaves has been actively conducted. Although a small amount of polyphenols present in olive leaves, as one of the groups of bioactive substances that are recently attracting attention, various physiological activities such as anti-cancer, anti-thrombotic, anti-inflammatory, anti-allergic and antimicrobial activities have been reported.
As a manufacturing method for the olive extract known so far, according to Korean Patent Publication No. 10-0449670 (name of the invention: a method for producing an olive powder and a composition for olive powder) according to the method for producing olive powder for taking for health food and olive The composition for powders is described. The present invention is to crush the olives and put corn flour and waxy corn starch into the stirrer to prepare olive powder to be individually packaged through a stirring mixing step, a freezing step, a drying step, a grinding step to make a composition for olive powder The present invention relates to a method for producing an olive leaf extract having a bioactivity of the present invention.
삭제delete
또한 올리브 잎의 생리활성에 관한 연구 보고들을 보면, 크게 항산화 효과, 항균효과 및 항고혈압에 대한 효과를 갖는 것으로 보고된 바 있다. 항산화 효과에 대한 연구로 Benavente-Garcia등[Benavente-Garcia, O., Castillo, J., Lorente, J., Ortuno, A. and Del Rio J.A. Antioxidant activity of phenolics extracted from Olea europaea L. leaves. Food Chem., 68(1): 457-462(2000)]은 올리브 잎 추출물에 존재하는 주요 페놀성 물질들을 분석하였고 이들 물질의 라디칼 소거능을 조사하였으며, 페놀성 물질들 중 람노즈가 당으로 결합한 형태의 flavonoid인 rutin이 가장 강한 항산화효과를 보였으며, flavone인 luteolin도 강력한 항산화효과를 나타낸다고 보고하였다. In addition, studies on the physiological activity of olive leaves have been reported to have a significant effect on the antioxidant, antimicrobial and antihypertensive. Studies on antioxidant effects include Benavente-Garcia et al. [Benavente-Garcia, O., Castillo, J., Lorente, J., Ortuno, A. and Del Rio J.A. Antioxidant activity of phenolics extracted from Olea europaea L. leaves. Food Chem., 68 (1): 457-462 (2000)] analyzed the major phenolic substances present in olive leaf extracts and investigated their radical scavenging ability. Rutin, the flavonoid form, showed the strongest antioxidant effect, and luteolin, the flavone, also showed the strong antioxidant effect.
이 밖에도 Somova 등[Somova, L.L., Shode, F.O., Ramnanan, P. and Nadar, A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J.Ethanopharmacology, 84:299-305(2003)]의 보고에서는 각각 재배지가 다른 올리브 잎으로부터 triterpenoids를 분리한 후, 이들의 항고혈압, 항동맥경화증 및 항산화효과 등을 조사하였다. In addition, Somova et al. [Somova, L.L., Shode, F.O., Ramnanan, P. and Nadar, A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J.Ethanopharmacology, 84: 299-305 (2003)], isolated triterpenoids from olive leaves of different cultivation sites and investigated their antihypertensive, anti-arteriosclerosis and antioxidant effects.
그러나, 생리활성에 관한 몇가지 연구들을 제외한 올리브 잎의 보고로는 계절변화에 따른 올리브 잎의 무기질 변화, 건조조건에 따른 올리브 잎의 화학성분의 변화, oleuropein의 소화대사 경로에 관한 연구 등이 있을 뿐 올리브 잎 추출물과 이들의 분획물에 대한 전반적인 생리활성에 관한 연구는 매우 미비한 실정이다. However, except for some studies on physiological activity, reports of olive leaves include only changes in minerals of olive leaves according to seasonal changes, changes in chemical composition of olive leaves according to drying conditions, and studies on the metabolic pathways of oleuropein. Studies on the overall biological activity of the olive leaf extract and their fractions are very incomplete.
본 발명의 목적은 생리활성을 갖는 올리브 잎 추출물 제조방법 및 이러한 방법을 이용하여 제조된 올리브 잎 추출물을 제공하는데 있다. 본 발명을 이용하여 올리브 잎을 추출하는 경우, 폴리페놀성분의 활성 저하없이 폴리페놀 성분을 다량 함유하는 올리브 잎 추출물을 제조할 수 있으며, 유기 용매를 사용하지 않으므로 식품으로 이용할 수 있는 안전한 추출물을 제공할 수 있다.SUMMARY OF THE INVENTION An object of the present invention is to provide an olive leaf extract manufacturing method having a physiological activity and an olive leaf extract prepared using the method. When extracting the olive leaf using the present invention, it is possible to prepare an olive leaf extract containing a large amount of polyphenol component without deteriorating the activity of the polyphenol component, and provides a safe extract that can be used as food because no organic solvent is used. can do.
이하 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 방법은 유기용매를 사용하지 않고 식용알코올인 에탄올을 사용하므로 안전한 올리브 잎 추출물을 제공할 수 있고, 또한 폴리페놀 활성의 저하없이 폴리페놀을 다량 함유하는 올리브 잎 추출물을 제공할 수 있다.
본 발명은 올리브 잎을 20 내지 30 메쉬(mesh)로 분쇄; 엘렌마이어 플라스크(Erlenmeyer flask)에 투입 80% 에탄올을 첨가; 85℃의 수조에서 5시간 동안 환류냉각(reflux) ; 여과(Whatman No.2) 단계를 포함한다. 이후 40℃에서 진공 농축 과정을 통하여 올리브 잎 추출물을 얻을 수 있으며, 이를 파우더로 제조하기 위하여 동결 건조하는 방법을 포함할 수도 있다.
이하 실시예를 들어 본 발명을 보다 구체적으로 설명하지만 본 발명이 이들 예로만 한정되는 것은 아니다.
식품에 이용될 수 있는 추출물을 제조하기 위하여 에탄올을 사용하였으며, 폴리페놀물질은 약간의 비극성을 띠기 때문에 에탄올 농도가 높을수록 추출이 잘 되나, 100%정도의 에탄올은 파우더로 제조하기에 어려운 문제가 있는바, 40% 및 80%에탄올을 사용하여 실험하였다. 또한 환류(reflux)시 온도를 85℃로 한정하였는데, 이는 에탄올을 이용하여 올리브 잎을 추출하기 위해 열을 공급해 주며 온도가 증가할수록 효율은 높으나, 에탄올의 끓는점은 85℃ 이하인바, 이 온도 이상으로 가열하는 것은 비효율적이므로, 상기의 온도값을 상한값으로 설정하였다.Since the method of the present invention uses ethanol which is an edible alcohol without using an organic solvent, it is possible to provide a safe olive leaf extract, and also to provide an olive leaf extract containing a large amount of polyphenol without degrading polyphenol activity.
The present invention is crushed
Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited only to these examples.
Ethanol was used to prepare extracts that can be used in foods. Polyphenols are slightly nonpolar, so the higher the ethanol concentration, the better the extraction. However, 100% ethanol is difficult to produce as a powder. The experiment was carried out using 40% and 80% ethanol. In addition, the temperature at reflux was limited to 85 ° C, which supplies heat to extract olive leaves using ethanol, and the efficiency increases as the temperature increases, but the boiling point of ethanol is below 85 ° C. Since heating is inefficient, the said temperature value was set to an upper limit.
삭제delete
삭제delete
삭제delete
(실시예1)Example 1
올리브 잎을 세척하여 이물질을 제거한 후 이를 40℃에서 열풍건조 시킨다. 이를 분쇄기(IKAM20, IKA, Germany)를 사용하여 20 내지 30 메쉬(mesh)로 조분쇄한 후 시료로 사용한다. 분쇄한 올리브 잎 10g을 플라스크에 투입한 후, 80% 에탄올 100㎖를 가하고 85℃ 수조에서 5시간 동안 환류냉각(reflux)한 다음, 이를 여과(Whatman No.2)한다. 여과하고 남은 잔사에 100㎖ 추출용매를 가하여 마찬가지 방법으로 추출하고 여과하며 이와같은 과정을 2회 반복한다. 3회 추출하여 얻은 여과액을 24시간 동안 4℃에서 정치, 10,000g로 원심분리, 40℃에서 감압농축하여 올리브 잎 추출물을 제조하며, 상기 과정을 거친 후, 이를 동결건조하여 분말로 된 올리브 잎 추출물을 제조할 수도 있다.(표 : 실험27)
(실시예2)After washing the olive leaves to remove the foreign matter it is dried by hot air at 40 ℃. This is used as a sample after coarsely pulverizing to 20 to 30 mesh using a grinder (IKAM20, IKA, Germany). 10 g of crushed olive leaves were added to the flask, and 100 ml of 80% ethanol was added thereto, refluxed for 5 hours in an 85 ° C water bath, and then filtered (Whatman No. 2). 100 ml of extraction solvent was added to the remaining residue after filtration, extraction and filtering were performed in the same manner, and the same procedure was repeated twice. The filtrate obtained by extracting three times was left standing at 4 ℃ for 24 hours, centrifuged at 10,000g, concentrated under reduced pressure at 40 ℃ to prepare an olive leaf extract, after the above process, lyophilized olive leaf powder Extracts can also be prepared (Table 27).
Example 2
삭제delete
올리브 잎을 세척하여 이물질을 제거한 후 이를 40℃에서 열풍건조 시킨다. 이를 분쇄기를 사용하여 20내지 30메쉬로 조분쇄한 후 시료로 사용한다. 분쇄한 올리브 잎 10g을 플라스크에 투입 한 후, 80%에탄올 100㎖ 를 가하고 25℃ 수조에서 1시간 동안 환류냉각을 한 다음, 이를 여과(Whatman No.2)한다. 여과하고 남은 잔사에 100㎖ 추출용매를 가하여 마찬가지 방법으로 추출하고 여과하며 이와같은 과정을 2회 반복한다. 3회 추출하여 얻은 여과액을 24시간 동안 4℃에서 정치, 10,000g로 원심분리, 40℃에서 감압농축하여 올리브 잎 추출물을 제조하며, 상기 과정을 거친 후, 이를 동결건조하여 분말로 된 생리활성을 갖는 올리브 잎 추출물을 제조할 수도 있다.(실험7)After washing the olive leaves to remove the foreign matter it is dried by hot air at 40 ℃. This is used as a sample after coarsely crushing into 20 to 30 mesh using a grinder. 10 g of pulverized olive leaves were added to the flask, and 100 ml of 80% ethanol was added thereto, and the mixture was cooled to reflux for 1 hour in a 25 ° C water bath, and then filtered (Whatman No. 2). 100 ml of extraction solvent was added to the remaining residue after filtration, extraction and filtering were performed in the same manner, and the same procedure was repeated twice. The filtrate obtained by extracting three times was left at 4 ℃ for 24 hours, centrifuged at 10,000g, concentrated under reduced pressure at 40 ℃ to prepare an olive leaf extract, after the above process, lyophilized to dry the powder biological activity Olive leaf extract may be prepared. (Experiment 7)
아래의 표는 추출온도, 추출용매, 추출시간에 따른 생리활성을 갖는 올리브 잎 추출물들의 성분 특성을 비교하여 생체 활성에 효과적인 적정 추출조건을 검색한 실험결과이다. The table below shows the results of experiments to find the proper extraction conditions effective for bioactivity by comparing the component properties of olive leaf extracts with physiological activity according to extraction temperature, extraction solvent, and extraction time.
<올리브 잎의 추출조건을 달리한 실시예><Examples with Different Extraction Conditions of Olive Leaves>
상기와 같은 실험을 통하여 생산된 추출물에 대하여 그 효과를 확인해보기 위하여 다음과 같은 실험을 실시하였다.In order to check the effect of the extract produced through the experiment as described above was carried out the following experiment.
(시험예1) 추출물들의 고형분 함량Test Example 1 Solid Contents of Extracts
생리활성을 갖는 올리브 잎 추출물들의 고형분 함량은 올리브 잎 추출물을 동결건조한 후 건고물의 무게를 측정한다. 추출조건에 따른 올리브 잎 추출물들의 고형분 함량은 아래의 표에 나타난 바와 같다. 추출온도가 높아질수록, 추출하는 에탄올의 농도가 높을수록 올리브 잎 추출물들의 고형분 함량은 증가하는 경향을 보인다. 그러나 추출시간의 경우, 고형분 함량과 추출시간들을 고려해 볼 때 고형분 함량이 가장 현저하게 높게 나타난 조건은 85℃, 80%에탄올, 5시간 추출한 처리구(38%)인 것으로 나타났다. Solid content of the olive leaf extracts having a physiological activity is measured after the freeze-dried olive leaf extract weight. The solid content of the olive leaf extracts according to the extraction conditions is shown in the table below. As the extraction temperature increases, the solid content of the olive leaf extracts tends to increase as the concentration of ethanol to be extracted increases. However, in the case of extraction time, considering the solid content and the extraction time, the condition that the solid content was most markedly high was 85 ° C., 80% ethanol, and treated for 5 hours (38%).
(시험예2) 추출조건에 따른 생리활성을 갖는 올리브 잎 추출물들의 총 페놀 함량Test Example 2 Total Phenolic Content of Olive Leaf Extracts with Physiological Activities According to Extraction Conditions
총 페놀 함량은 Folin-Dennis법에 의하여 분석하였다. 즉, Folin-Dennis시약은 sodium tungstate 10g, phosphomolybdic 2g, pfosphoric acid 5㎖를 메스플라스크에 넣고 증류수로 정용한 후 삼각플라스크에 옮겨 2시간 동안 환류조작한다. 구체적으로, 캡튜브에 증류스 7㎖씩 넣고 DMSO(dimethylsulfoxide)에 녹인 시료를 1㎖씩 넣은 후 Folin-Dennis 시약을 0.5㎖를 첨가 후 3분 후에 sodium carbonate anhydrous 포화용액 1㎖, 증류수 0.5㎖를 넣은 후 725nm에서 흡광도를 측정하여 표준용액과 비교하여 총 페놀 함량을 구한다. 표준용액으로는 tannic acid를 사용하 였다.Total phenol content was analyzed by Folin-Dennis method. In other words, Folin-Dennis reagent is added 10g sodium tungstate, 2g phosphomolybdic, 5ml pfosphoric acid into a volumetric flask, and then distilled water, and then into a conical flask to reflux for 2 hours. Specifically, 7 ml of distillate was added to the cap tube, and 1 ml of the sample dissolved in DMSO (dimethylsulfoxide) was added, and 0.5 ml of the Folin-Dennis reagent was added. After 3 minutes, 1 ml of saturated sodium carbonate anhydrous solution and 0.5 ml of distilled water were added. After adding the absorbance at 725 nm, compare with the standard solution to determine the total phenol content. Tannic acid was used as the standard solution.
추출조건에 따른 올리브 잎 추출물들의 총 페놀 함량을 비교하면, 추출용매의 에탄올 농도가 높아질수록 증가하는 경향을 보였다. 총 페놀 함량이 가장 높게 나타난 추출조건은 25℃에서 80% 에탄올로 1시간 추출한 처리구였으며, 이때 총 페놀 함량은 22.1%이다.Comparing the total phenolic content of the olive leaf extracts according to the extraction conditions, the ethanol concentration of the extractant increased. The extraction condition that showed the highest total phenol content was treated with 80% ethanol at 25 ° C for 1 hour, and the total phenol content was 22.1%.
(시험예3) 추출조건에 따른 생리활성을 갖는 올리브 잎 추출물들의 전자 공여능Test Example 3 Electron Donating Ability of Olive Leaf Extracts with Physiological Activity According to Extraction Conditions
생리활성을 갖는 올리브 잎 추출물들의 전자공여능은 DPPH radical 소거능을 이용하여 측정한다. 즉, Blois 방법을 응용하여 캡튜브에 3.5Ⅹ10-3 M DPPH/EtOH 용액 3㎖과 DMSO에 녹인 시료 0.15㎖을 혼합하여 실온에서 30분간 방치한 후 516nm에서 흡광도를 측정하였으며, 다음 식에 의하여 DPPH radical 소거효과를 계산하였다.The electron donating ability of olive leaf extracts with physiological activity was measured using DPPH radical scavenging ability. That is, by applying the Blois method, 3 ml of a 3.5Ⅹ10 -3 M DPPH / EtOH solution and 0.15 ml of a sample dissolved in DMSO were mixed in a cap tube and left at room temperature for 30 minutes, and the absorbance was measured at 516 nm. The radical scavenging effect was calculated.
EDA(%) = 1- SA/CA Ⅹ 100EDA (%) = 1- SA /
SA : sample absorbance SA: sample absorbance
CA : control absorbanceCA: control absorbance
추출조건에 따른 올리브 잎 추출물들의 전자공여능을 측정한 결과, 추출용매의 에탄올 농도가 높아질수록 전자공여능도 증가하는 경향을 보였다. 이는 추출조건에 따른 올리브 잎 추출물들의 총 페놀 함량에 대한 결과와 같은 경향으로 25℃에서 80%에탄올로 1시간 추출한 추출물에서 70.5%의 강한 전자공여능을 나타낸다. 이는 생리활성을 갖는 올리브 잎 추출물들에 존재하는 페놀성 화합물들에 기인한 것으로 페놀성 화합물들 구조내에 존재하는 hydroxyl group(-OH)에 의한 강한 라디칼 소거효과를 보인 것이다. As a result of measuring the electron donating ability of the olive leaf extracts according to the extraction conditions, the electron donating ability also increased as the ethanol concentration of the extraction solvent increased. This is the same trend as the result of the total phenolic content of the olive leaf extracts according to the extraction conditions shows a strong electron donating ability of 70.5% in the extract extracted with 80% ethanol at 25 ℃ for 1 hour. This is due to the phenolic compounds present in the olive leaf extracts having physiological activity and showed a strong radical scavenging effect by the hydroxyl group (-OH) present in the phenolic compounds structure.
<생리 활성을 갖는 올리브 잎 추출물의 고형분 함량, 총 페놀 함량 및 전자 공여능><Solid Content, Total Phenolic Content and Electron Donating Ability of Olive Leaf Extracts with Physiological Activity>
이하의 실험은 실시예1에 따른 방법에 의하여 제조된 추출물 및 이를 용매의 극성에 따라 다시 유기용매로 분획한 분획물의 생리활성을 측정한 실험이다. 이는 실시예1의 추출물에 함유된 폴리페놀성분이 실제로 생리활성을 갖는지 알아보기 위한 실험으로서, 다음과 같은 방법에 의한다. The following experiment is an experiment measuring the physiological activity of the extract prepared by the method according to Example 1 and the fraction fractionated again with an organic solvent according to the polarity of the solvent. This is an experiment to determine whether the polyphenol component contained in the extract of Example 1 actually has a physiological activity, by the following method.
실시예1에 따른 에탄올 추출물을 극성이 다른 용매를 이용하여 각각 단계적으로 분획한다. 실시예1에 따른 추출물을 물에 녹여 분획여두에 넣고 헥산을 첨가하여 헥산층과 물층을 분획한 후 50℃에서 감압농축하여 헥산 분획물을 얻는다. 동일한 방법으로 클로로포름, 에틸아세테이트, 부탄올을 순차적으로 가하여 클로로포름, 에틸아세테이트, 부탄올 및 물 분획물을 각각 얻었다. 이들 분획물들을 감압농축 및 진공건조하여 용매를 완전히 제거한 후 고형분의 함량을 측정한다.The ethanol extract according to Example 1 was fractionated in each step using solvents of different polarities. The extract according to Example 1 was dissolved in water, put into a fractional filter, hexane was added, the hexane layer and the water layer were partitioned, and concentrated under reduced pressure at 50 ° C. to obtain a hexane fraction. In the same manner, chloroform, ethyl acetate and butanol were added sequentially to obtain chloroform, ethyl acetate, butanol and water fractions, respectively. These fractions were concentrated under reduced pressure and dried in vacuo to completely remove the solvent and then measure the content of solids.
(시험예1) 아질산염 소거능 Test Example 1 Nitrite Scavenging Ability
아질산염 소거작용은 Gray와 Dugan의 방법에 의하여 측정하였다. 즉, 1mM NaNO2용액 1mL에 일정농도의 시료 1mL를 가하고 0.1N HCl(pH1.2)로 반응용액의 pH를 1.2로 조정한 다음 총량을 10mL로 하였다. 이 용액을 37℃에서 1시간 반응시킨 후 각 반응액을 1mL씩 취하여 2% 초산용액 5mL과 Griess시약(30% acetic acid로 조제한 1% sulfanilic acid와 1%naphthylamine을 1:1 비율로 혼합한 것, 사용 직전에 조제) 0.4mL을 가하여 잘 혼합하였다. 이 혼합액을 실온에서 15분간 방치한 후 UV/Vis spectrophotometer를 이용하여 520nm에서 흡광도를 측정, 잔존하는 아질산 량을 구하였다. 공 시험은 Griess시약 대신 증류수를 0.4mL 가하여 동일하게 행하였다. 아질산염 소거작용은 시료를 첨가한 경우와 첨가하지 않은 경우의 아질산염 백분율로써 나타낸다.Nitrite scavenging activity was measured by the method of Gray and Dugan. That is, 1 mL of a certain concentration of sample was added to 1 mL of 1 mM NaNO 2 solution, the pH of the reaction solution was adjusted to 1.2 with 0.1 N HCl (pH 1.2), and the total amount was 10 mL. After reacting this solution at 37 ° C for 1 hour, take 1 mL of each reaction solution, and
N(%) = 1 - (A-C)/B * 100N (%) = 1-(A-C) / B * 100
N : 아질산염 소거능N: nitrite scavenging ability
A : 1시간 동안 반응한 후, 1mM NaNO2를 첨가한 샘플의 흡광도A: Absorbance of the sample to which 1 mM NaNO 2 was added after reacting for 1 hour.
B : 1mM NaNO2 흡광도B: 1 mM NaNO 2 absorbance
C : 조절(control) 흡광도C: control absorbance
상기와 같은 실험을 pH 1.2 조건에서 측정, 비교한 결과는 도1과 같다. The above experiment was measured and compared at pH 1.2, and the results are shown in FIG. 1.
(도 1, H:엑산 분획물, C:클로로포증 분획물, E:에틸 아세테이트 분획물, (FIG. 1, H: exion fraction, C: chlorophosity fraction, E: ethyl acetate fraction,
B : 부탄올 분획물, W : 물 분획물) B: butanol fraction, W: water fraction)
실시예1에 의한 아질산염 소거능은 추출물의 농도가 0.01-0.5%로 증가할수록 8.1-72.8%로 추출물의 농도에 비례하여 아질산염 소거능도 증가하는 경향을 보인다. 분획물들 중에서는 0.5%농도에서 부탄올 분획물과 에틸아세테이트 분획물에서 각각 76.0%와 75.4%로 유의적으로 높은 값을 나타내었다. 이와같은 결과로 볼 때, 올리브 잎 분획물들의 아질산염 소거능은 각각의 분획물들에 함유된 총 플라보노이드 및 총페놀 함량에 비례적인 관게를 보였으며 총 플라보노이드 및 총페놀 함량이 높게 나타난 부탄올 분획물과 에틸아세테이트 분획물에서 아질산염 소거능의 효과가 높게 나타나는 상관관계를 보인다. Nitrite scavenging ability according to Example 1 shows a tendency to increase nitrite scavenging ability in proportion to the concentration of the extract to 8.1-72.8% as the concentration of the extract increases to 0.01-0.5%. Among the fractions, butanol and ethyl acetate fractions were significantly higher at 7% and 75.4%, respectively, at 0.5% concentration. As a result, the nitrite scavenging ability of olive leaf fractions was proportional to the total flavonoid and total phenol content in each fraction, and the butanol and ethyl acetate fractions showed high contents of total flavonoid and total phenol. The correlation between nitrite scavenging effect is high.
(시험예2) 항균활성 측정Test Example 2 Antibacterial Activity
실시예1에 따른 추출물과 용매별 분획물들의 항균효과 검색은 paper disc법을 이용하여 측정하였다. 향균효과 측정에 사용된 균주는 gram양성균과 gram음성균 각각 2종류씩 사용하였다. 각 시험균주를 해당 액체 배지에 24시간 전배양 하였고, 평판배지의 조제는 각각의 생육배지로 멸균된 1.5% agar를 petridish에 20 ㎖씩 분주하여 응고시킨 후 각 시험균액을 0.1 ㎖씩 첨가하여 멸균된 유리봉으로 배지위에 고르게 펴지도록 도포하여 사용하였다. 용매별 분획물들을 일정농도로 주입한 paper disc를 평판배지 위에 흡착시켜 멸균수 30㎕를 주입 후 37℃에서 24시간 배양하여 paper disc 주변의 inhibition clear zone의 직경(mm)을 측정하여 올리브 잎 80% 에탄올 추출물 및 각각의 분획물들에 대한 항균효과를 비교, 분석하였다. Searching for the antimicrobial effect of the extracts and fractions by solvent according to Example 1 was measured using the paper disc method. Two strains, Gram-positive bacteria and Gram-negative bacteria, were used for the antibacterial effect measurement. Each test strain was precultured in the corresponding liquid medium for 24 hours, and the plate medium was prepared by coagulation by dispensing 1.5 ml of agar sterilized with each growth medium into 20 ml of petridish and adding 0.1 ml of each test bacteria. The glass rods were applied to spread evenly on the medium. After absorbing the paper disc in which the solvent-specific fractions were injected at a certain concentration on a plate medium, 30 μl of sterilized water was injected, and incubated at 37 ° C. for 24 hours to measure the diameter (mm) of the inhibition clear zone around the paper disc. The antimicrobial effect on ethanol extracts and their respective fractions was compared and analyzed.
실시예1에 따른 추출물과 각각의 분획물들에 대한 항균효과에 대한 결과는 아래의 표에 도시된 바와 같다. 실시예1의 추출물의 경우 gram양성균인 Bacillus cereus, Staphylococcus aureus와 gram음성균인 Escherichia coli, Salmonella enteritidis 모드에서 강한 향균효과를 보인다. 실시예1의 추출물 농도와 항균효과간의 관계를 살펴보면, 추출물의 농도가 증가함에 따라 상기 균의 향균효과도 증가하는 경향을 보인다. The results of the antimicrobial effect on the extracts and the respective fractions according to Example 1 are shown in the table below. The extract of Example 1 shows strong antibacterial effect in gram-positive bacteria Bacillus cereus, Staphylococcus aureus and gram-negative bacteria Escherichia coli, Salmonella enteritidis mode. Looking at the relationship between the extract concentration and the antimicrobial effect of Example 1, as the concentration of the extract increases, the antibacterial effect of the bacteria also tends to increase.
각각의 분획물들에 대한 항균효과는 부탄올 분획물과 에틸아세테이트 분획물에서만 상기 균에 대한 강한 향균효과를 보였다.The antimicrobial effect of each fraction showed a strong antimicrobial effect against the bacteria only in the butanol fraction and ethyl acetate fraction.
<실시예1에 의한 추출물 및 분획물들의 항균활성><Antibacterial activity of extracts and fractions according to Example 1>
H : 헥산 분획물H: Hexane Fraction
C : 클로로포름 분획물,C: chloroform fraction,
E : 에틸 아세테이트 분획물,E: ethyl acetate fraction,
B : 부탄올 분획물,B: butanol fraction,
W : 물 분획물.W: water fraction.
(시험예3) SOD 유사활성Test Example 3 SOD-like Activity
실시예 1에 따라 추출된 추출물 및 각각의 분획물들에 대한 효소계 시스템에서의 라디칼 소거능을 측정하고자 SOD 유사활성을 검색하였다. Superoxide라디칼 소거활성은 Lio등의 방법에 따라 xanthine-xanthine oxidase cytochrome C환원법으 로 측정하였다. 즉, 시료 0.2 ㎖, 50mM PBS(phosphate buffered saline) 완충용액(pH7.8) 1.2 ㎖, 1mM xanthine 0.2mL와 0.05mM cytochrome C 0.2mL를 혼합하였다. 여기에 550nm에서 분당 흡광도의 변화가 0.02가 되도록 희석한 xanthine oxidase 0.2mL를 가하여 3분간의 흡광도 변화를 측정하였다. 이때 superoxide anion의 소거능은 아래의 식으로부터 구하였다. SOD-like activity was searched to determine the radical scavenging ability in the enzyme-based system for the extract extracted in accordance with Example 1 and the respective fractions. Superoxide radical scavenging activity was measured by xanthine-xanthine oxidase cytochrome C reduction method according to Lio et al. That is, 0.2 ml of sample, 1.2 ml of 50 mM PBS (phosphate buffered saline) buffer (pH7.8), 0.2 ml of 1 mM xanthine and 0.2 ml of 0.05 mM cytochrome C were mixed. To this was added 0.2 mL of xanthine oxidase diluted so that the change in absorbance per minute at 550 nm was 0.02. The scavenging ability of superoxide anion was calculated from the following equation.
Superoxide anion scavenging activity = (1-Abs/Abc)*100Superoxide anion scavenging activity = (1-Abs / Abc) * 100
Abc : 550nm에서 제어 흡광도ABC: controlled absorbance at 550nm
Abs : 550nm에서 표본 처리 후의 흡광도Abs: absorbance after sample treatment at 550 nm
실시예1에 따른 추출물과 이의 분획물에 대한 유사활성은 도2에 도시된 바와 같다. 실시예 1에 따른 추출물의 SOD유사활성은 추출물의 농도가 1mg/mL에서는 21.1%의 활성을 보였으나 10mg/mL의 농도에서는 53.1%의 활성을 보여 추출물의 농도가 증가할 수록 SOD 유사활성도 증가하는 경향을 보인다. Similar activity for the extract according to Example 1 and its fractions is as shown in FIG. The SOD-like activity of the extract according to Example 1 showed 21.1% of the activity at the concentration of 1 mg / mL, but showed 53.1% of the activity at the concentration of 10 mg / mL. Show a tendency.
분획물등 중에서는 10mg/mL 농도에서 부탄올 분획물과 에틸아세테이트 분획물에서 각각 85.4%와 86.3%로 유의적으로 높은 값을 나타낸다. Among the fractions, butanol and ethyl acetate fractions showed significantly higher values of 85.4% and 86.3%, respectively, at a concentration of 10 mg / mL.
(도 2, H:엑산 분획물, C:클로로포증 분획물, E:에틸 아세테이트 분획물, (FIG. 2, H: exion fraction, C: chlorophosity fraction, E: ethyl acetate fraction,
B : 부탄올 분획물, W : 물 분획물) B: butanol fraction, W: water fraction)
(시험예4) 리놀레인산 기질에서의 항산화효과 측정Experiment 4 Measurement of Antioxidant Effect on Linoleic Acid Substrate
리놀레인산 기질에서의 항산화효과는 실험군 이외에 대조군과 비교군을 가지 고 실험하였다. 대조군은 첨가물을 넣지 않은 리놀레인산 50g을 사용하였으며 실험군은 리놀레인산 50g에 대하여 실시예1에 따른 추출물 및 각각의 분획물들을 0.02%(w/w)의 농도로 첨가하였고, 비교군은 리놀레인산 50g에 합성항산화제 BHT, 천연항산화제 α-tocopherol을 각각 0.02%(w/w)의 농도로 첨가하여 실험하였다. 조제된 시료는 55 ±1℃ 항온기에 저장하면서 12시간 간격으로 과산화물가를 측정, 비교하였으며 저장 중 과산화물가의 변화에 따른 유도기간 설정은 과산화물가가 50meq/kg oil에 도달하는데 걸리는 시간으로 하였다. 과산화물가의 측정은 일정량의 시료를 chloroform/acetic acid 용액(20:30%v/v) 30 ㎖에 녹인 후 포화 KI(potassium iodide) 용액을 가하여 I2를 유리시켜 I2의 농도를 알고 있는 Na2S2O3(sodium thiosulfate) 표준 용액으로 적정한 후 과산화물가의 양을 다음 식에 의하여 산출하였다.Antioxidant effect on linoleic acid substrate was tested with control group and comparison group. The control group used 50 g of linoleic acid without any additives, and the experimental group added the extract according to Example 1 and the respective fractions at a concentration of 0.02% (w / w) with respect to 50 g of linoleic acid. To 50 g of acid, synthetic antioxidant BHT and natural antioxidant α-tocopherol were added at a concentration of 0.02% (w / w), respectively. The peroxide value was measured and compared at 12 hours intervals while storing the prepared samples in a 55 ± 1 ℃ incubator. The induction period setting according to the change of peroxide value during storage was the time taken for the peroxide value to reach 50 meq / kg oil. The measurement solution for a predetermined amount of the sample chloroform / acetic acid in gwasanhwamulga (20: 30% v / v ) was dissolved in 30 ㎖ to liberate the I 2 was added to a saturated KI (potassium iodide) solution of Na 2 known concentration of I 2 After titration with S 2 O 3 (sodium thiosulfate) standard solution, the amount of peroxide was calculated by the following equation.
POV(meq/㎏oil) = ((A-B)*N/S) * 100POV (meq / kgoil) = ((A-B) * N / S) * 100
A : titration of sample, mLA: titration of sample, mL
B : titration of blank, mLB: titration of blank, mL
S : weight of sample (g)S: weight of sample (g)
N : normality of sodium thiosulfate solutionN: normality of sodium thiosulfate solution
상기와 같은 실험의 결과는 도3 및 도4에 도시된 바와 같다.The results of the above experiment are as shown in FIGS. 3 and 4.
도3에서 보는 바와 같이, 저장 84시간 때의 올리브 잎 80%에탄올 추출물의 과산화물가는 80.1meq/㎏ 오일로 negative control인 대조구의 과산화물가에 비해 낮은 값을 보인다. Positive control로 사용된 항산화제들과 비교해 보면, 저장 84시간 때의 BHT 및 α-토코페롤의 과산화물가는 각각 65.8 및 78.7meq/㎏ 오일로 대조구나 실시예1에 비해 큰 항산화 효과를 보인다.As shown in FIG. 3, the peroxide value of the 80% ethanol extract of the olive leaf at 84 hours of storage was 80.1 meq / kg oil, which was lower than that of the control which was negative control. Compared with the antioxidants used as the positive control, the peroxide values of BHT and α-tocopherol at 84 hours of storage were 65.8 and 78.7 meq / kg oil, respectively, showing a greater antioxidant effect than the control or Example 1.
도4에서 보는 바와 같이, 올리브 잎 분획물들의 첨가에 따른 리놀레인산의 과산화물가 변화를 측정한 결과 저장84시간 때의 헥산, 클로로포름, 에틸아세테이트, 부탄올 및 물 분획물들의 과산화물가는 각각 88.3, 83.3, 77.5, 66.3 및 83.3meq/㎏ 오일로 나타나 부탄올 분획물과 에틸아세테이트 분획물에서 과산화물 생성을 억제하는 것으로 나타난다. As shown in FIG. 4, the peroxide value of linoleic acid with the addition of olive leaf fractions was measured, and the peroxide values of hexane, chloroform, ethyl acetate, butanol and water fractions were 88.3, 83.3, 77.5, respectively. It appears as 66.3 and 83.3 meq / kg oils and appears to inhibit peroxide production in butanol fraction and ethyl acetate fraction.
(시험예5) 리놀레인산 에멀젼 시스템에서의 항산화효과 측정Test Example 5 Measurement of Antioxidant Effect in Linoleic Acid Emulsion System
실시예1에 의한 추출물 및 각각의 분획물들에 의한 리놀레인산 에멀젼 기질에서의 과산화물 생성 억제효과를 측정하였다. 레놀레인산 에멀젼 기질을 제조하는 방법으로는 리놀레인산 2.6 mL를 99.5% 에탄올 100mL에 용해시킨 후 10mL씩 취하여 conical tube에 넣고 올리브 잎 80%에탄올 추출물 및 각각의 분획물들과 항산화제의 농도가 0.02%가 되도록 각각 첨가한 후, 0.1 M phosphate buffer(pH7.0)를 10mL, 증류수 4.5mL 가하여 40 ±1℃ 항온기에 저장하면서 하루 간격으로 과산화물의 변화를 측정하였다. 리놀레인산 에멀젼 시스템에서의 과산화물 함량 변화는 thiocyanate 법을 사용하여 측정하였다. 측정방법으로 75% 에탄올 4.7mL에 각 시료 0.1mL와 30% 암모늄 시아네이트 0.1mL를 넣고, 정확히 3분 후 20 mM iron(Ⅱ )chloride (in 3.5% HCl) 0.1mL를 첨가한 후, 500nm에서 UV/Vis spectrophotometer로 흡광도의 변화를 측정하여 각 시료의 과산화물 함량의 지표로 삼았다.The inhibitory effect of peroxide production on the linoleic acid emulsion substrate by the extract according to Example 1 and the respective fractions was measured. A method for preparing a lenoleic acid emulsion substrate is to dissolve 2.6 mL of linoleic acid in 100 mL of 99.5% ethanol, and then take 10 mL of each into a conical tube and extract 80% ethanol extract of olive leaf, and the concentration of each fraction and antioxidant is 0.02. After each addition to the%, 0.1mL phosphate buffer (pH7.0) was added to 10mL, 4.5mL of distilled water and stored in a 40 ± 1 ℃ constant temperature and the change of peroxide was measured at day interval. Changes in peroxide content in the linoleic acid emulsion system were measured using the thiocyanate method. As a measuring method, add 0.1 mL of each sample and 0.1 mL of 30% ammonium cyanate to 4.7 mL of 75% ethanol, and after exactly 3 minutes, add 0.1 mL of 20 mM iron (II) chloride (in 3.5% HCl) at 500 nm. Changes in absorbance were measured with a UV / Vis spectrophotometer as an indicator of peroxide content in each sample.
실시예1의 추출물에 따른 결과는 도5에 도시되었으며, 각각의 분획물들의 항산화 효과는 도6에 도시된 바와 같다.The results according to the extract of Example 1 are shown in Figure 5, the antioxidant effect of each fraction is as shown in Figure 6.
도5에서 실시예1의 추출물, BHT, α-토코페롤 및 대조구 과산화물 함량 변화를 비교한 결과 저장초기 값은 0.064였으나 대조구의 경우 저장4일만에 2.277로, α-토코페롤은 저장1일만에 2.209로, BHT는 저장 25일만에 2.18로 저장기간이 증가함에 따라 과산화물의 함량도 증가하는 경향을 보인다. 반면, 실시예1에 따른 추출물의 경우 저장 43일까지도 0.362의 낮은 증가치를 보여 positive control인 BHT나 α-토코페롤에 비해 우수한 항산화효과를 나타낸다. In FIG. 5, when the extract, BHT, α-tocopherol and control peroxide contents of Example 1 were compared, the initial storage value was 0.064, but the control group was 2.277 after 4 days of storage, and α-tocopherol was 2.209 after 1 day of storage. BHT tends to increase in peroxide content as the storage period increases to 2.18 after 25 days of storage. On the other hand, the extract according to Example 1 shows a low increase of 0.362 even after 43 days of storage, showing an excellent antioxidant effect compared to the positive control BHT or α-tocopherol.
도6에 의하면, 에틸아세테이트 분획물과 부탄올 분획물에서 가장 좋은 효과를 보인다. According to Figure 6, the ethyl acetate fraction and butanol fraction shows the best effect.
(시험예6) 가열산화시 올리브 잎 분획물들의 항산화 효과 Test Example 6 Antioxidant Effect of Olive Leaf Fractions During Heating Oxidation
실시예1에 의한 추출물 및 각각의 분획물들의 첨가에 따른 가열산화시 튀김유의 산패억제 효과를 알아보고자 실시예1에 따른 추출물 및 각각의 분획물들의 농도를 0.02%로 하여 대두유에 첨가한 후 테스트 튜브에 10g씩 나누어 담아, 180 ±2℃로 유지된 오일조(oil bath)에서 48시간 동안 가열산화 시키면서 12시간 간격으로 산가(acid value), 공액이중산가(conjugated diene value) 및 굴절률의 변화를 측정하여 실시예1의 추출물 및 각각의 분획물들의 항산화효과를 측정해보았다. 산 가는 A.O.C.S공정법 Cd-3a-63에 따라 측정하였다. 즉, 시료 5g을 정확히 삼각플라스크에 넣고 이에 100mL 에탄올-에테르 혼합액 (1:1. v/v)을 가하여 용해시킨 후 1% 페놀프탈레인용액 2-3방울 가하여 0.1 N KOH용액으로 옅은 분홍색이 30초간 지속될 때까지 적정하였다. 산가는 다음의 식에 의해 산출한다.In order to determine the rancidity inhibitory effect of frying oil during heating oxidation according to the addition of the extract according to Example 1 and the respective fractions, the concentration of the extract and the respective fractions according to Example 1 was added to soybean oil at a concentration of 0.02% and then added to the test tube. Divided into 10g each, the change of acid value, conjugated diene value and refractive index were measured at 12 hour intervals while heating and oxidizing for 48 hours in an oil bath maintained at 180 ± 2 ℃. The antioxidant effects of the extract of Example 1 and the respective fractions were measured. Acid value was measured according to A.O.C.S process method Cd-3a-63. In other words, 5 g of the sample is accurately placed in an Erlenmeyer flask, and 100 mL of ethanol-ether mixture (1: 1. V / v) is added to dissolve it. Then, 2-3 drops of 1% phenolphthalein solution is added, and a light pink color is continued for 30 seconds with 0.1 N KOH solution. Titration until The acid value is calculated by the following equation.
Acid value = ((A-B)*F*N)/SAcid value = ((A-B) * F * N) / S
A : 적정시 사용된 표준 알칼리의 mLA: mL of standard alkali used for titration
B : 적정 비교실험시 사용된 표준 알칼리 mLB: mL of standard alkali used in titration comparison experiment
N : 표준 알칼리 노르말농도N: standard alkali normal concentration
S : 시료 중량(g)S: sample weight (g)
공액이중산가의 변화는 A.O.C.S 공정법 Ti-la 64에 따라 측정하였다. 즉, 100mL용량 플라스크에 90 내지 130 mg 정도의 시료유지를 취한 후 75mL의 isooctane을 넣고 유지를 완전히 용해하여 isooctane으로 정용하였다. 필요에 따라 10배를 넘지 않는 범위에서 희석하면서 UV/Vis spectrophotometer를 이용하여 233nm에서 흡광도를 측정하였다. 측정된 시료의 공액이중산가는 다음의 식에 의해 구한다.The change of conjugated double acid value was measured according to A.O.C.S process method Ti-la 64. In other words, after taking a sample of about 90 to 130 mg in a 100 mL flask, 75 mL of isooctane was added thereto, and the fats and oils were completely dissolved and used as isooctane. If necessary, the absorbance was measured at 233 nm using a UV / Vis spectrophotometer while diluting in a range not exceeding 10 times. The conjugated double acid value of the measured sample is obtained by the following equation.
공액이중산가 = 0.84 * (AS/bs - K0)Conjugated double acid value = 0.84 * (AS / bs-K 0 )
K0 : 산 또는 에스터족에 의한 흡광도 (산:0.03, 에스터족:0.07)K 0 : absorbance by acid or ester (acid: 0.03, ester: 0.07)
AS : 233nm에서의 측정 흡광도AS: absorbance measured at 233 nm
b : cell 길이(cm)b: cell length (cm)
s : 흡광도 측정을 위해 사용된 오일의 최종 희석 농도(g/l)s: final dilution concentration (g / l) of oil used for absorbance measurement
가열산화에 대한 실시예1의 추출물 및 각각의 분획물들의 공액이중산가, 산가 및 굴절률의 변화를 측정한 결과는 도7 내지 도10 및 아래의 표에 도시된 바와 같다. The results of measuring the change in conjugated double acid value, acid value and refractive index of the extract of Example 1 and the respective fractions for the heating oxidation are shown in FIGS. 7 to 10 and the table below.
올리브 잎의 생리활성 물질에 대하여 조사하기 위하여 생리활성 물질의 분리, 정제 및 그 구조를 결정하는 실험을 다음과 같이 실시하였다. In order to investigate the bioactive substances of olive leaves, experiments to determine the separation, purification and structure of the bioactive substances were carried out as follows.
(시험예1)Test Example 1
올리브 잎의 생리활성 물질을 분리하기 위하여 실시예1에 따른 추출물을 부탄올로 분획한 후 HPLC로 분리, 정제하여 5개의 OLB 1내지5를 얻는다. 이들 분획물들 중 DPPH radical 소거능이 가장 강하게 나타난 OLB5에 대해서만 재차 HPLC를 실 시하여 OLB 5-1 및 OLB 5-2를 분리, 정제한다. 도11 및 도12의 결과로 보아 올리브 잎에 주요 페놀성 물질이 oleuropein임을 확인할 수 있다.In order to separate the bioactive substance of the olive leaf, the extract according to Example 1 was fractionated with butanol, and then separated and purified by HPLC to obtain five
(시험예2)Test Example 2
OLB 5-1의 H-NMR스펙트럼 및 C-NMR스펙트럼을 조사한 결과, 올리브 잎 부탄올 분획물로부터 분리된 상기 물질은 상기와 같은 구조의 oleuropein인 것을 알 수 있다. As a result of examining the H-NMR spectrum and the C-NMR spectrum of OLB 5-1, it can be seen that the material separated from the olive leaf butanol fraction is oleuropein having the above structure.
이상에서 설명한 바와같이, 본 발명에 따른 방법에 의하여 올리브 잎 추출물을 제조하는 경우, 활성의 저하가 없으며 페놀류를 다량 함유하는 올리브 잎 추출물을 제공할 수 있으며, 이는 항균활성, 항산화효과 등 다양한 생체효과를 갖는 것으로서, 다양한 식품에 활용할 수 있다.As described above, when preparing the olive leaf extract by the method according to the present invention, there is no decrease in activity and can provide an olive leaf extract containing a large amount of phenols, which has a variety of biological effects such as antibacterial activity, antioxidant effect As having, it can be utilized in various foods.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050078206A KR100740416B1 (en) | 2005-08-25 | 2005-08-25 | Process of manufacturing of olive leaf extract with physiological activities |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050078206A KR100740416B1 (en) | 2005-08-25 | 2005-08-25 | Process of manufacturing of olive leaf extract with physiological activities |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070023896A KR20070023896A (en) | 2007-03-02 |
KR100740416B1 true KR100740416B1 (en) | 2007-07-16 |
Family
ID=38098702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050078206A KR100740416B1 (en) | 2005-08-25 | 2005-08-25 | Process of manufacturing of olive leaf extract with physiological activities |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100740416B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714150A (en) | 1997-01-08 | 1998-02-03 | Nachman; Leslie | Method for producing extract of olive leaves |
JPH11155537A (en) | 1997-12-03 | 1999-06-15 | Kuniyasu Okamura | Production of eucommia ulmoides oliver leaf tea |
US6309652B1 (en) | 1996-06-08 | 2001-10-30 | Nestec S.A. | Extraction of olives for obtaining antioxidant compositions |
JP2002128678A (en) | 2000-10-17 | 2002-05-09 | Tama Seikagaku Kk | Method for producing extract composition containing oleuropein |
US6838092B2 (en) | 2002-04-09 | 2005-01-04 | Aboca S.P.A. | Effervescent compositions containing dried fruit juices |
-
2005
- 2005-08-25 KR KR1020050078206A patent/KR100740416B1/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309652B1 (en) | 1996-06-08 | 2001-10-30 | Nestec S.A. | Extraction of olives for obtaining antioxidant compositions |
US5714150A (en) | 1997-01-08 | 1998-02-03 | Nachman; Leslie | Method for producing extract of olive leaves |
JPH11155537A (en) | 1997-12-03 | 1999-06-15 | Kuniyasu Okamura | Production of eucommia ulmoides oliver leaf tea |
JP2002128678A (en) | 2000-10-17 | 2002-05-09 | Tama Seikagaku Kk | Method for producing extract composition containing oleuropein |
US6838092B2 (en) | 2002-04-09 | 2005-01-04 | Aboca S.P.A. | Effervescent compositions containing dried fruit juices |
Also Published As
Publication number | Publication date |
---|---|
KR20070023896A (en) | 2007-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mohdaly et al. | Phenolic extract from propolis and bee pollen: composition, antioxidant and antibacterial activities | |
Ng et al. | Customized drying treatments increased the extraction of phytochemicals and antioxidant activity from economically viable medicinal plants | |
Adedapo et al. | Assessment of the medicinal potentials of the methanol extracts of the leaves and stems of Buddleja saligna | |
Premanath et al. | Studies on anti-oxidant activity of Tinospora cordifolia (Miers.) leaves using in vitro models | |
Karima et al. | Antioxidant and antimicrobial activities of Plantago major | |
Ramadan et al. | Lipid profile, antiradical power and antimicrobial properties of Syzygium aromaticum oil | |
Hosseini et al. | Total phenol, antioxidant and antibacterial activity of the essential oil and extracts of Ferulago angulata ssp. angulata | |
Hadrich et al. | Valorization of the peel of pea: Pisum sativum by evaluation of its antioxidant and antimicrobial activities | |
Vidic et al. | Determination of total phenolic content and antioxidant activity of ethanol extracts from Aloe spp | |
Rama et al. | In vitro antioxidant activity of Achyranthes aspera Linn | |
Chimshirova et al. | EXTRACTION OF VALUABLE COMPOUNDS FROM BULGARIAN ST. JOHN'S WORT (HYPERICUM PERFORATUM L.). ANTIOXIDANT CAPACITY AND TOTAL POLYPHENOLIC CONTENT. | |
Benattia et al. | Antioxidative and antiradical activities of bioactive compounds of extracts from Algerian prickly pear (Opuntia ficus-indica. L) fruits | |
Oliveira et al. | Antioxidant and antigenotoxic activities of Ginkgo biloba L. leaf extract are retained after in vitro gastrointestinal digestive conditions | |
Wagdy et al. | Primary assessment of the biological activity of jojoba hull extracts | |
CHOUIKH et al. | Phytochemical study, nutritive value, antioxidant and anti-inflammatory activities of phenolic extracts from desert plant Calligonum comosum L'Hér. | |
Aissaoui et al. | Structural characterization of phenolic content, antioxidant and antibacterial activities of Coffea arabica green seeds | |
Erian et al. | Total polyphenols, flavonoids content and antioxidant activity of crude methanolic and aqueous extracts for some medicinal plant flowers | |
Sokamte et al. | Antioxidant and antimicrobial activities of two edibles spices from Cameroon and quantification of their major phenolic compounds. | |
Rachida et al. | Screening of phenolic compounds from Abelmoschus esculentus L extract fruits and in vitro evaluation of antioxidant and antibacterial activities | |
KR100740416B1 (en) | Process of manufacturing of olive leaf extract with physiological activities | |
KR20130023778A (en) | Anti-cancer composition which comprising chlorophylls from isolated green tea | |
Kiran et al. | In vitro evaluation of antioxidant potentiality of seeds of Psoralea corylifolia L | |
Benslama et al. | In vitro antioxidant, antibacterial activities and HPLC-TOF/MS analysis of Anvillea radiata (Asteraceae) extracts | |
Karimkhani et al. | Effect of extraction solvents on total phenolic compound, lipid peroxidation, antioxidant and cytotoxic activity of leaves of Rubus armeniacus (Himalayan blackberry) | |
Boukhalfa et al. | Antioxidant capacity and anti-inflammatory potential of two extracts of Ficus carica leaves dried in the shade and in the oven |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100625 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |